You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – GenMark Diagnostics reported after the close of the market on Wednesday that its third quarter revenues increased 104 percent year over year, driven in part by ePlex Respiratory Pathogen Panel 2 (RP2) sales.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.